Wedbush upgraded shares of Wingstop (NASDAQ:WING) from a neutral rating to an outperform rating in a research report released on Thursday morning, MarketBeat Ratings reports. The firm currently has $59.00 price objective on the restaurant operator’s stock, up from their previous price objec
The Food and Drug Administration (FDA) announced a shame list of companies that try to block generic drugs in order to ramp up profits.
Pharmaceutical companies argue that they spend billions of dollars to research and develop new drugs, which they don’t want competitors profiting from by making cheaper generic copies of these medicines. These companies often fight for patent extensions,....More>>>
Why do some companies’ shares trade at $100 or more each while others trade at substantially less? There are many factors that contribute to the price of a stock, the most important being the number of shares outstanding. After all, the share price multiplied by the number of shares available determines a company’s market cap, which is the true price at which the market values a company.
The storage market has enjoyed a tremendous run over the past few years. With demand for high-capacity storage exploding in order to feed the trend in big data processing, enterprises and hyperscale cloud computing vendors have been buying memory of all types hand-over-fist.
Western Digital (NASDAQ:WDC) makes non-volatile memory (which retains data even when power is turned off), both on....More>>>
Flippin Bruce & Porter Inc. decreased its holdings in Emerson Electric (NYSE:EMR) by 33.6% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 66,251 shares of the industrial products company’s stock after s
Flippin Bruce & Porter Inc. decreased its holdings in Emerson Electric (NYSE:EMR) by 33.6% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 66,251 shares of the industrial products company’s stock after se
Equities research analysts expect that Conatus Pharmaceuticals (NASDAQ:CNAT) will post earnings per share of ($0.20) for the current fiscal quarter, Zacks reports. Six analysts have issued estimates for Conatus Pharmaceuticals’ earnings, with the lowest EPS estimate coming in at ($0.35) a
Nike(NYSE:NKE), Under Armour (NYSE:UAA)(NYSE:UA), and other clothing brands have been talking a lot lately about the need to overhaul their manufacturing processes as a way to reduce costs, improve quality, and have more flexibility. The textile manufacturing process has changed relatively s
A smart operator will when he realizes things have not worked out, fold up his tent and move on before he is knocked out of the game for good. One disastrous restaurant venture can drag down an entire string of successful ones, as I have seen many times. - Anthony Bourdain